S. Majest

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +14

Synthesis of 4,5-Diaryl-1<i>H</i>-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors

Meena Patel, Randy L. Bell, S. Majest et al. · The Journal of Organic Chemistry · 2004 · 91 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers

Anthony Rusk, Evelyn McKeegan, Fortuna Haviv et al. · Clinical Cancer Research · 2006 · 77 citations

Medicine, Oncology, Pharmacology +13

ABT-963 [2-(3,4-Difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2 H-pyridazin-3-one], A Highly Potent and Selective Disubstituted Pyridazinone Cyclooxgenase-2 Inhibitor

Richard R. Harris, Lawrence A. Black, Sekhar Surapaneni et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 45 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5

George S. Sheppard, Megumi Kawai, Richard A. Craig et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10